| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0920-9964(99)00218-2 |
| P698 | PubMed publication ID | 11343869 |
| P2093 | author name string | K Müller | |
| L C Andersson | |||
| R Rimón | |||
| A Ahokas | |||
| H V Nikkilä | |||
| P2860 | cites work | Stimulated lymphocytes in schizophrenia | Q72519231 |
| Immunophenotypic studies on atypical lymphocytes in psychiatric patients | Q74440856 | ||
| ABNORMAL LEUKOCYTES IN SCHIZOPHRENIA | Q76533115 | ||
| The effects of monocytes on the transendothelial migration of T lymphocytes | Q77312768 | ||
| Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism | Q31960799 | ||
| Expression of dopamine receptors in immune organs and circulating immune cells | Q36846056 | ||
| Immunopathology and viral reactivation. A general theory of schizophrenia. | Q37998877 | ||
| Activated T lymphocytes in cerebrospinal fluid of patients with HTLV-I-associated myelopathy (HAM/TSP). | Q39093105 | ||
| Infection and autoimmunity as etiologic factors in schizophrenia: a review and reappraisal | Q40821139 | ||
| Antigen presenting capacity of brain microvasculature in altered peptide ligand modulation of experimental allergic encephalomyelitis | Q40946533 | ||
| Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? | Q41376152 | ||
| Diagnostic value of atypical lymphocytes in cerebrospinal fluid from adults with enteroviral meningitis | Q44654184 | ||
| Medication effect on lymphocyte morphology in schizophrenia | Q44664494 | ||
| The C-terminal tetrapeptide of beta-endorphin (MPF) enhances lymphocyte proliferative responses | Q47930883 | ||
| Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy | Q48432118 | ||
| Further studies of elevated cerebrospinal fluid neuronal cell adhesion molecule in schizophrenia | Q48471636 | ||
| Abnormal expression of cell recognition molecules in schizophrenia | Q48512855 | ||
| A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures | Q48519543 | ||
| Childhood-onset schizophrenia. Progressive ventricular change during adolescence | Q48615047 | ||
| Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia | Q48660056 | ||
| Increased numbers of CD5+ B lymphocytes in schizophrenic patients. | Q52064228 | ||
| Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. | Q54756947 | ||
| Microglia: Intrinsic immuneffector cell of the brain | Q56029409 | ||
| Reduced frequency of memory CD8+ T lymphocytes in cerebrospinal fluid and blood of patients with multiple sclerosis. | Q64996320 | ||
| Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity | Q67666310 | ||
| Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers | Q69839595 | ||
| The anatomy of the P lymphocyte | Q70565770 | ||
| Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes | Q71941608 | ||
| Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia | Q72277313 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 99-105 | |
| P577 | publication date | 2001-04-01 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia | |
| P478 | volume | 49 |
| Q92535351 | A Cross-Species Systems Genetics Analysis Links APBB1IP as a Candidate for Schizophrenia and Prepulse Inhibition |
| Q38801096 | A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia. |
| Q38544976 | Adaptive Immunity in Schizophrenia: Functional Implications of T Cells in the Etiology, Course and Treatment |
| Q38467000 | Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia |
| Q37968946 | Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand? |
| Q58940038 | Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis |
| Q80817756 | Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia |
| Q24800061 | Endocannabinoid signalling in the blood of patients with schizophrenia |
| Q36043407 | Immunological findings in psychotic syndromes: a tertiary care hospital's CSF sample of 180 patients |
| Q26781620 | Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment |
| Q27002489 | Inflammation and schizophrenia |
| Q38779149 | Is it time for immunopsychiatry in psychotic disorders? |
| Q73419127 | Lymphocytes from bipolar and schizophrenic patients share common biochemical markers related to histone synthesis and histone cell membrane localization characteristic of an activated state |
| Q37275549 | Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects |
| Q39432877 | Psychosis: an autoimmune disease? |
| Q58940446 | The Role of Infections and Autoimmune Diseases for Schizophrenia and Depression: Findings from Large-Scale Epidemiological Studies |
| Q38646326 | The blood-brain barrier in psychosis |
| Q38809444 | Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions |
Search more.